For example, studies have been looking at the use of GLP-1s for reducing the risk of cardiovascular disease and chronic kidney disease, treatment of nonalcoholic fatty liver disease and Now, two new studies recently presented at the 2026 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS) offer insights on how GLP-1 medications might influence musculoskeletal health, both positively and negatively
Download from Apple and Google Play app stores
Your care team can help you adjust your treatment plan, explore alternative compounds like tirzepatide, or investigate whether genetic factors (revealed by the Precision Peptide Genetic Test) suggest a different peptide protocol might work better for your physiology
For instance, patients with a specific GLP1R genotype variant may tolerate tirzepatide (a dual GIP/GLP-1 receptor agonist) better than semaglutide alone, while others benefit more from the microdose approach
PLoS ONE 9 , e104519 (2014)
If you notice no stimulating effects, evening dosing is also acceptable